It’s great that Bessent showed up to the party, but where was Ueda?

Changes to two most widely cited claims come as scrutiny grows over US tech company’s contract

Amid geopolitical barriers that risk slowing progress and trade, Europe can become a trusted connector

Governments have stopped correcting budget deficits but — so far — bond markets have let them

Generals lose their current wars by fighting the last one. And regulators in the City of London and on the continent are creating a new crisis because they’re making exactly that mistake.

Prysmian expands North American footprint with $3.8B Atkore acquisition

Worldline announces the finalisation of the sale of its Indian payment activities to BillDesk

A puzzling intervention

AstraZeneca has explored an acquisition of Bristol Myers Squibb, according to people familiar with the matter. It’s unclear if discussions are ongoing or whether they will result in a transaction, the people cautioned. A representative for AstraZeneca declined to comment and Bristol Myers Squibb cou

FTSE 100 Live: UK Stocks Lag, Gilts Rise as US-Iran Optimism Weighs on Oil